Laszlo Lencs

Laszlo Lencs is a founding partner of KNP Law – Nagy-Koppány Lencs and Partners, an international law firm based in Budapest, and the recipient of the Pharmaceutical Sector Law Expert of the Year in Hungary award at the 2024 Corporate INTL Global Awards. As one of the attorneys who established the firm, he has helped shape a practice that has become closely identified with pharmaceutical and life sciences law in Hungary, advising participants in one of the country's most heavily regulated industries.

KNP Law was founded in 2006 by a group of lawyers whose legal education and training were drawn from Hungary, the United States and other European Union countries, and Lencs was among the founding partners alongside Kornelia Nagy-Koppány. That international grounding has remained a defining characteristic of the firm, which brings together a team of around twenty-five people, from partners to support staff, to serve domestic and cross-border clients. The firm's outlook reflects the backgrounds of its founders, combining Hungarian legal expertise with familiarity with US and EU legal systems.

The practice is primarily focused on pharmaceutical and life sciences law, the field in which Lencs is recognised, and it has more recently developed a strand of work in renewable energy law. Alongside these areas it also handles mergers and acquisitions, data protection, labour and employment, and real estate. This combination allows the firm to support pharmaceutical and life sciences companies not only on the sector-specific regulation that governs their products but also on the corporate, employment and data matters that arise in the ordinary course of their business, offering an integrated service to companies operating in a complex regulatory environment.

Lencs's engagement with the wider pharmaceutical policy debate is reflected in his participation in industry discussions on the future of the sector's regulation. He has taken part in a roundtable on the implications of proposed new EU pharmaceutical legislation at the Annual Pharma Seminar of the Conférence Bleue, the European network of law firms specialising in the pharmaceutical, healthcare and medical fields. Involvement in such forums keeps the firm's advice aligned with developments at European level, an important consideration for clients whose products are subject to both national and EU rules.

Pharmaceutical sector law demands an understanding of the regulatory frameworks governing the development, authorisation, marketing and distribution of medicines, as well as the commercial and compliance issues that accompany them. As a founding partner of a firm built around this discipline, Lencs occupies a central place in a practice that has advised the sector in Hungary since 2006. The recognition conferred by the 2024 Corporate INTL Global Awards affirms his standing as a leading pharmaceutical sector lawyer in Hungary and reflects the reputation that KNP Law has established as a specialist adviser to the life sciences industry, combining sector focus with the international perspective that its founders brought to the firm from the outset.